{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:15:27Z","timestamp":1791220527422,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21791555"],"award-info":[{"award-number":["21791555"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22390308"],"award-info":[{"award-number":["22390308"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23592447"],"award-info":[{"award-number":["23592447"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24249080"],"award-info":[{"award-number":["24249080"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006062","name":"Foundation for Promotion of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008880","name":"Kanae Foundation for the Promotion of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ajpath.2013.01.039","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T20:57:06Z","timestamp":1363381026000},"page":"1876-1889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin \u03b15 Expression"],"prefix":"10.1016","volume":"182","author":[{"given":"Chifumi","family":"Ohyagi-Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kamiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuto","family":"Kinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Mabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hisamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Kumasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenori","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichirou","family":"Morishige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Kurachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.01.039_bib1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2013.01.039_bib2","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2013.01.039_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3802\/jgo.2010.21.2.75","article-title":"Maximal cytoreductive effort in epithelial ovarian cancer surgery","volume":"21","author":"Shih","year":"2010","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2013.01.039_bib5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib6","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajpath.2013.01.039_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcp.21240","article-title":"Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm","volume":"213","author":"Ahmed","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer: shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib11","doi-asserted-by":"crossref","first-page":"915140","DOI":"10.1155\/2012\/915140","article-title":"Integrin inhibitors as a therapeutic agent for ovarian cancer","volume":"2012","author":"Sawada","year":"2012","journal-title":"J Oncol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-0-387-98094-2_16","article-title":"Organotypic models of metastasis: a three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis","volume":"149","author":"Kenny","year":"2009","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ajpath.2013.01.039_bib13","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0002-9440(10)63058-1","article-title":"Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids","volume":"159","author":"Casey","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.1999.5388","article-title":"Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in\u00a0vitro","volume":"73","author":"Strobel","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib15","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","article-title":"Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target","volume":"68","author":"Sawada","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.01.039_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2013.01.039_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/carcin\/bgr081","article-title":"MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1","volume":"32","author":"Wang","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2013.01.039_bib18","doi-asserted-by":"crossref","first-page":"D140","DOI":"10.1093\/nar\/gkj112","article-title":"miRBase: microRNA sequences, targets and gene nomenclature","volume":"34","author":"Griffiths-Jones","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2013.01.039_bib19","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2013.01.039_bib20","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1242\/jcs.077529","article-title":"MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2","volume":"124","author":"Shatseva","year":"2011","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.ajpath.2013.01.039_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14728222.2012.663354","article-title":"Exploiting the therapeutic potential of microRNAs in human cancer","volume":"16","author":"Cho","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.ajpath.2013.01.039_bib22","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.1073\/pnas.0704372104","article-title":"Let-7 expression defines two differentiation stages of cancer","volume":"104","author":"Shell","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2013.01.039_bib23","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.01.039_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1471-2105-10-295","article-title":"Accurate microRNA target prediction correlates with protein repression levels","volume":"10","author":"Maragkakis","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ajpath.2013.01.039_bib25","doi-asserted-by":"crossref","first-page":"W273","DOI":"10.1093\/nar\/gkp292","article-title":"DIANA-microT web server: elucidating microRNA functions through target prediction","volume":"37","author":"Maragkakis","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2013.01.039_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2013.01.039_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.ajpath.2013.01.039_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MicroRNA targeting specificity in mammals: determinants beyond seed pairing","volume":"27","author":"Grimson","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2013.01.039_bib29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nsmb.2115","article-title":"Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs","volume":"18","author":"Garcia","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib30","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1158\/1535-7163.MCT-09-0965","article-title":"mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities","volume":"9","author":"Liu","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ajpath.2013.01.039_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2013.01.039_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(92)90115-S","article-title":"Integrins: versatility, modulation, and signaling in cell adhesion","volume":"69","author":"Hynes","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2013.01.039_bib33","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.01.039_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.7716514","article-title":"Integrins and signal transduction pathways: the road taken","volume":"268","author":"Clark","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.01.039_bib35","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.cell.2009.05.038","article-title":"New hope for a microRNA therapy for liver cancer","volume":"137","author":"Rossi","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2013.01.039_bib36","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1158\/0008-5472.CAN-06-0800","article-title":"MicroRNA-cancer connection: the beginning of a new tale","volume":"66","author":"Calin","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.01.039_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1998.5071","article-title":"Clinical characteristics of clear cell carcinoma of the ovary","volume":"70","author":"Behbakht","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2010.12.362","article-title":"A phase II, single-arm study of the anti-\u03b15\u03b21 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer","volume":"121","author":"Bell-McGuinn","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib39","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/sj.bjc.6603171","article-title":"Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours","volume":"94","author":"Cianfrocca","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2013.01.039_bib40","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.01.039_bib41","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","article-title":"Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters","volume":"132","author":"Ventura","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2013.01.039_bib42","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.4161\/cc.8.23.9994","article-title":"The microRNA-17-92 cluster: still a miRacle?","volume":"8","author":"Bonauer","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ajpath.2013.01.039_bib43","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","article-title":"Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma","volume":"64","author":"Ota","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.01.039_bib44","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjc.6605037","article-title":"MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression","volume":"101","author":"Diosdado","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2013.01.039_bib45","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2353\/ajpath.2008.080096","article-title":"Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype","volume":"173","author":"Connolly","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib46","doi-asserted-by":"crossref","first-page":"10725","DOI":"10.1074\/jbc.M110.165654","article-title":"microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.01.039_bib47","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2013.01.039_bib48","doi-asserted-by":"crossref","first-page":"e36051","DOI":"10.1371\/journal.pone.0036051","article-title":"Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration","volume":"7","author":"Nilsson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2013.01.039_bib49","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.01.039_bib50","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","article-title":"MicroRNAs in cancer: small molecules with a huge impact","volume":"27","author":"Iorio","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.01.039_bib51","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-10-0655","article-title":"Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34","volume":"70","author":"Wiggins","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.01.039_bib52","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013001260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013001260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:44:38Z","timestamp":1757601878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013001260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0002944013001260"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.01.039","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin \u03b15 Expression","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}